QA: Arqule INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001019695_2018_Arqule_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001019695, Arqule INC

  xvar xval
0 AssetsCurrent 48,583,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 115,000
3 remainder_Assets 204,000
4 LiabilitiesCurrent 9,759,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,550,088
9 ResearchAndDevelopmentExpense 19,551,721
10 remainder_Expenses 1,366,771
11 remainder_Revenues 0
12 remainder_NetIncome -387,221
13 remainder_ComprehensiveNetIncome -13,689
  yvar yval
0 Assets 48,902,000
1 Liabilities 9,759,000
2 Expenses 28,468,580
3 Revenues 0
4 StockholdersEquity 39,143,000
5 NetIncome -28,855,801
6 ComprehensiveNetIncome -28,862,646
7 BaseVar 43,765,245
8 EconomicCapitalRatiobeforeLimitedLiability 1.93
9 EconomicCapitalRatio 2.97

Edgar->Model Mapping

Feature Distribution

Change over Time